Toward a third term of Health Japan 21 – implications from the rise in non-communicable disease burden and highly preventable risk factors

Nomura, 2017, Population health and regional variations of disease burden in Japan, 1990-2015: a systematic subnational analysis for the global burden of disease study 2015, Lancet, 390, 1521, 10.1016/S0140-6736(17)31544-1 Ministry of Health, Labour and Welfare. Overview of national healthcare expenditures in 2018 [Japanese]. 2020. https://www.mhlw.go.jp/toukei/saikin/hw/k-iryohi/18/index.html (accessed October 29, 2021). Sakurai, 2003, Healthy Japan 21, Japan Med Assoc J, 46, 47 Ezoe, 2017, Trends in policy on the prevention and control of non-communicable diseases in Japan, Health Syst Reform, 3, 268, 10.1080/23288604.2017.1347125 Ministry of Health, Labour and Welfare. Health Japan 21: final evaluation [Japanese]. 2011. http://www.mhlw.go.jp/stf/houdou/2r9852000001r5gc-att/2r9852000001r5np.pdf (accessed October 29, 2021). Institute for Health Metrics and Evaluation. Global Burden of Disease (GBD). 2020. http://www.healthdata.org/gbd/2019 (accessed October 29, 2021). Kim, 2012, Data for better health–and to help end poverty, Lancet, 380, 2055, 10.1016/S0140-6736(12)62162-X Murray, 1997, Understanding DALYs (disability-adjusted life years), J Health Econ, 16, 703, 10.1016/S0167-6296(97)00004-0 2020, Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019, Lancet, 396, 1223, 10.1016/S0140-6736(20)30752-2 2020, Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019, Lancet, 396, 1204, 10.1016/S0140-6736(20)30925-9 2020, Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019, Lancet, 396, 1160, 10.1016/S0140-6736(20)30977-6 Institute for Health Metrics and Evaluation. GBD Results Tool. http://ghdx.healthdata.org/gbd-results-tool (accessed May 12, 2021). Inoue, 2012, Attributable causes of cancer in Japan in 2005–systematic assessment to estimate current burden of cancer attributable to known preventable risk factors in Japan, Ann Oncol, 23, 1362, 10.1093/annonc/mdr437 Inoue, 2021, Burden of cancer attributable to modifiable factors in Japan in 2015, Glob Health Med Lin, 2021, Burden of cancer attributable to infection in Japan in 2015, GHM Open, 1, 63, 10.35772/ghmo.2021.01016 Plummer, 2016, Global burden of cancers attributable to infections in 2012: a synthetic analysis, Lancet Glob Health, 4, e609, 10.1016/S2214-109X(16)30143-7 IHME. Global Burden of Disease Study 2019 (GBD 2019) population estimates: 1950-2019. 2020. http://ghdx.healthdata.org/record/ihme-data/gbd-2019-population-estimates-1950-2019 (accessed July 4, 2021). Miyata, 2015, Japan's vision for health care in 2035, Lancet, 385, 2549, 10.1016/S0140-6736(15)61135-7 Sakamoto, 2018 Shimokata, 2019, Healthy life expectancy in Japan – A comparative study of healthy life expectancy between the Global Burden of Disease and Comprehensive Survey of Living Conditions [Japanese], Annual Report of Institute of Health and Nutrition Nagoya University of Arts and Sciences, 21 Ministry of Health, Labour and Welfare. Report on the interim evaluation of Health Japan 21 (2nd term) [Japanese]. 2018. https://www.mhlw.go.jp/content/000378318.pdf (accessed October 29, 2021). Tsuji, 2020, Current status and issues concerning Health Japan 21 (second term), Nutr Rev, 78, 14, 10.1093/nutrit/nuaa079 World Health Organization. NCD Global Monitoring Framework – ensuring progress on noncommunicable diseases in countries. 2011 (accessed October 29, 2021). Olsen, 2016, A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension, Lancet, 388, 2665, 10.1016/S0140-6736(16)31134-5 Gencer, 2020, Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials, Lancet, 396, 1637, 10.1016/S0140-6736(20)32332-1 Emerging Risk Factors, 2010, Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies, Lancet, 375, 2215, 10.1016/S0140-6736(10)60484-9 Prince, 2015, The burden of disease in older people and implications for health policy and practice, Lancet, 385, 549, 10.1016/S0140-6736(14)61347-7 Dagenais, 2008, A systematic review of low back pain cost of illness studies in the United States and internationally, Spine J, 8, 8, 10.1016/j.spinee.2007.10.005 Hartvigsen, 2018, What low back pain is and why we need to pay attention, Lancet, 391, 2356, 10.1016/S0140-6736(18)30480-X Huang, 2014, Retrospective analysis of the economic burden of long-term care facility residents diagnosed with Alzheimer's disease in the United States, Value Health, 17, A512, 10.1016/j.jval.2014.08.1574 2019, Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016, Lancet Neurol, 18, 88, 10.1016/S1474-4422(18)30403-4 Livingston, 2020, Dementia prevention, intervention, and care: 2020 report of the Lancet Commission, Lancet, 396, 413, 10.1016/S0140-6736(20)30367-6 2017 2021, Hearing loss prevalence and years lived with disability, 1990-2019: findings from the Global Burden of Disease Study 2019, Lancet, 397, 996, 10.1016/S0140-6736(21)00516-X 2016, Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants, Lancet, 387, 1377, 10.1016/S0140-6736(16)30054-X 2020, Five insights from the Global Burden of Disease Study 2019, Lancet, 396, 1135, 10.1016/S0140-6736(20)31404-5 Nomura, 2020, Limited alignment of publicly competitive disease funding with disease burden in Japan, PLoS One, 15, 10.1371/journal.pone.0228542 Ministry of Health, Labour and Welfare. Report of the National Health and Nutrition Survey, 2019 [Japanese]. 2020. https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou_iryou/kenkou/eiyou/r1-houkoku_00002.html (accessed October 29, 2021). World Health Organization. WHO Framework Convention on Tobacco Control. 2003. https://www.who.int/fctc/text_download/en/(accessed October 29, 2021). Katanoda, 2014, Tobacco control challenges in East Asia: proposals for change in the world's largest epidemic region, Tob Control, 23, 359, 10.1136/tobaccocontrol-2012-050852 Nomura, 2019, The 2020 Tokyo Olympic & Paralympic Games: time for Japan to showcase smokefree hospitality, BMJ Tanigaki, 2019, Challenges and opportunities for greater tobacco control in Japan, Int J Drug Policy, 70, 78, 10.1016/j.drugpo.2019.05.008 Summan, 2020, The potential global gains in health and revenue from increased taxation of tobacco, alcohol and sugar-sweetened beverages: a modelling analysis, BMJ Glob Health, 5, 10.1136/bmjgh-2019-002143 Jamison, 2013, Global health 2035: a world converging within a generation, Lancet, 382, 1898, 10.1016/S0140-6736(13)62105-4 Ikeda, 2011, Japan: Universal Health Care at 50 Years 1 What has made the population of Japan healthy?, Lancet, 378, 1094, 10.1016/S0140-6736(11)61055-6 Umemura, 2019, The Japanese Society of Hypertension Guidelines for the management of hypertension (JSH 2019), Hypertens Res, 42, 1235, 10.1038/s41440-019-0284-9 Hashimoto, 2011, Cost containment and quality of care in Japan: is there a trade-off?, Lancet, 378, 1174, 10.1016/S0140-6736(11)60987-2 Nomura, 2020, Forecasting disability-adjusted life years for chronic diseases: reference and alternative scenarios of salt intake for 2017-2040 in Japan, BMC Public Health, 20, 1475, 10.1186/s12889-020-09596-3 Yoneoka, 2020, Prediction of disability-adjusted life years for diseases due to low fruit intake in 2017-2040 in Japan, Public Health Nutr, 1 Tanaka, 2021, Projections of disability-adjusted life years for major diseases due to a change in vegetable intake in 2017-2040 in Japan, BMC Public Health, 21, 770, 10.1186/s12889-021-10772-2 de Figueiredo, 2020, Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study, Lancet, 396, 898, 10.1016/S0140-6736(20)31558-0 Gilmour, 2013, HPV vaccination programme in Japan, Lancet, 382, 768, 10.1016/S0140-6736(13)61831-0 Williamson, 2020, Factors associated with COVID-19-related death using OpenSAFELY, Nature, 584, 430, 10.1038/s41586-020-2521-4 Drozd, 2021, Non-communicable disease, sociodemographic factors, and risk of death from infection: a UK Biobank observational cohort study, Lancet Infect Dis, 10.1016/S1473-3099(20)30978-6 NCD Alliance. COVID-19 and Noncommunicable Diseases (NCDs): Questions and Answers. 2020. https://ncdalliance.org/resources/covid-19-and-noncommunicable-diseases-ncds-questions-and-answers (accessed October 29, 2021). Yin, 2017, Relationship of sleep duration with all-cause mortality and cardiovascular events: a systematic review and dose-response meta-analysis of prospective Cohort Studies, J Am Heart Assoc, 6, 10.1161/JAHA.117.005947 Ervasti, 2021, Long working hours and risk of 50 health conditions and mortality outcomes: a multicohort study in four European countries, The Lancet Regional Health – Europe, 11, 10.1016/j.lanepe.2021.100212